FDA Inspection 798055 — Antares Pharma, Inc.
The FDA completed an inspection of Antares Pharma, Inc. on September 6, 2012 in Minnetonka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Minnetonka, MN (United States)